OAC
IMGN

OMERS Administration Corp’s Immunogen Inc IMGN Stock Holding History

OMERS Administration Corp’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26,400
Closed -$419K – 340
2023
Q3 		$419K Buy
+26,400
New +$439K 0.01% 112

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

OMERS Administration Corp's IMGN Position: Q4 2023 in Review

OMERS Administration Corp sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 26,400 shares — an estimated $419K sold.

OMERS Administration Corp first reported a position in IMGN in Q3 2023 and held it in 1 quarter. The position peaked at $419K in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • OMERS Administration Corp reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • OMERS Administration Corp sold 26,400 Immunogen Inc shares in Q4 2023, an estimated $419K.
  • OMERS Administration Corp first reported a position in Immunogen Inc in Q3 2023 and held it in 1 quarter.
  • OMERS Administration Corp's Immunogen Inc position peaked at $419K in Q3 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on OMERS Administration Corp's 13F filing for Q4 2023, filed 13 Feb 2024.